Allied Market Research
Loading...
0
New
New
2021
Infection Surveillance Services Market

Infection Surveillance Services Market by Offering (Software and Services), Infection Type (Hospital-acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infections (UTIs), and Others), and End User (Hospitals & Clinics, Ambulatory Surgical Centers & Academic Institutes, and Long-term Care Facilities): Global Opportunity Analysis and Industry Forecast, 2021––2030

A13109
Pages: 246
Aug 2021 | 171 Views
   
Author(s) : Linu Dash , Onkar Sumant
Tables: 123
Charts: 36
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Infection Surveillance Services Market

Request Now !

Infection Surveillance Services Market Overview:

The global infection surveillance services market size was valued at $407.06 million in 2020, and is projected to reach $1,724.22 million by 2030, registering a CAGR of 14.5% from 2021 to 2030. Infection surveillance service is defined as the service used to measure the success of infection prevention and control programs to identify the area of improvement. The infection surveillance service offers and collects the national data, which are used in benchmarking rates of surgical site infection. It is designed to continuously monitor and interpret the data related to health to ensure accurate implementation of preventive measures.

The COVID-19 outbreak is anticipated to have a positive impact on the growth of the global infection surveillance services market. The COVID-19 pandemic has stressed the healthcare systems in the world and increased the risk of developing healthcare-associated infection among COVID-19 patients.

The growth of the global infection surveillance services market is majorly driven by increase in prevalence of healthcare associated infection, rise in funding from private & government organizations for various programs related to infection surveillance, surge in number of surgical procedures, surge in geriatric population which is more susceptible to healthcare-associated infections, and rise in adoption of infection surveillance software among healthcare workers. According to the Centers for Disease Control and Prevention (CDC), it was reported that approximately 1.7 million infections and 99,000 deaths are reported for healthcare-associated infection, in the U.S., every year. For instance, in 2020, BioMerieux, a global leader in the field of in vitro diagnostics for infectious disease, announced the launch of CLARION, which is an infectious disease diagnostics software-as-a-service (SaaS) solution and connect diagnostic data in the U.S.. In addition, rise in resistance of microbes toward antibiotics fuels the market growth. According to the Association of Medical Microbiology and Infectious Disease Canada, in 2019, it was reported that healthcare-associated infectious diseases in Canada were caused due to prolonged use of antibiotics for Lyme disease. Furthermore, in June 2021, the European Centre for Disease Prevention and Control announced the launch of the European surveillance portal, EpiPulse for infectious disease. It aims to collect, share, and analyze the data of infectious diseases for further monitoring services. 

infection-surveillance-services-market

Get more information on this report : Request Sample Pages

However, high cost of software associated with infection surveillance services is expected to restrict the market growth during the forecast period.

Infection Surveillance Services Market Segmentation

The infection surveillance services market is segmented into offering, infection type, end user, and region. By offering, the market is categorized into software and services. The software segment is further classified into on-premise and web-based. The services segment is subdivided into product support & maintenance services, training & consulting services, and implementation services. On the basis of infection type, the market is segregated into hospital-acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infections (UTI), and others.

Depending end user, the market is fragmented into hospitals & clinics, ambulatory surgical centers & academic institutes, and long-term care facilities.

Region-wise, the infection surveillance services market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Segment review

Depending on offering, the software segment dominated the market in 2020, and is expected to continue this trend during the forecast period, owing to increase in prevalence of healthcare-associated infection and increase in demand for infection surveillance software by healthcare sectors. However, the services segment is expected to witness considerable infection surveillance services market growth during the forecast period, owing to increase in demand for services used in hospital, rise in prevalence of hospital-acquired infection, and rise in adoption of infection surveillance software among healthcare workers.

Infection Surveillance Services Market
By Offering

Your browser does not support the canvas element.

Software segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

On the basis of infection type, the surgical site infections acquired the largest share of infection surveillance services market in the year 2020. The growth of this segment is due to factors such as surge in the number of surgical procedures performed across the globe which in turn lead to rise in risk of surgical site infections. In addition, hospital acquired pneumonia segment is expected to exhibit fastest growth rate during the forecast period. The high growth rate of this segment is due to the increase in use of mechanical ventilation in patients hospitalized in intensive care units. Furthermore, it is also attributed to an aging population, and the introduction of sophisticated surgical procedures for treatment of neurological, oncological and other critical illness. Hence, this in turn leads to rise in risk for hospital acquired pneumonia which drives the growth of the market.

Infection Surveillance Services Market
By Infection Type

Your browser does not support the canvas element.

Surgical Site Infections segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

On the basis of end user, the hospital & clinics segment dominated the market in 2020, and is expected to continue this trend during the forecast period, owing to increase in prevalence of healthcare-associated infection and surge in demand for electronic medical record. However, long-term care facilities segment is expected to witness considerable growth during the forecast period, owing to increase in in number of surgeries, rise in prevalence of surgical site infections, and surge in demand for effective management of infection.

Infection Surveillance Services Market
By End User

Your browser does not support the canvas element.

Hospitals and Clinics segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

North America accounted for a major share in the infection surveillance services market in 2020, and is expected to maintain its dominance during the forecast period, owing to rise in prevalence of healthcare-associated infections, presence of key players, increase in healthcare expenditure, advancements in analytical & infectious surveillance solution, and rise in government initiatives to prevent healthcare-associated infections in the region. However, Asia-Pacific is expected to register highest CAGR of 16.6% from 2021 to 2030, due to increase in prevalence of hospital-acquired infection, rise in geriatric population, increase in trend of self-medication, and rise in adoption of infection surveillance software among healthcare workers.

Infection Surveillance Services Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

North America was holding a dominant position in 2020 and would continue to maintain the lead over the analysis period.

Get more information on this report : Request Sample Pages

The key players operating in the global infection surveillance services market include Alpha Source Inc., Baxter International Inc., Becton, Dickinson and Company, BioVigil, Gojo Industries Inc., International Business Machines Corporation, Premier Inc., RLDatix, S. C. Johnson & Son, Inc., and Wolters Kluwer.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the infection surveillance services market, and the current trends and future estimations to elucidate imminent investment pockets.
  • It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing infection surveillance services market opportunities.
  • Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Key Market Segments

By Offering

  • Software
    • On-premise
    • Web-based
  • Services
    • Product Support & Maintenance Services
    • Training & Consulting Services
    • Implementation Services

By Infection Type

  • Hospital-acquired Pneumonia
  • Bloodstream Infections
  • Surgical Site Infections
  • Gastrointestinal Infections
  • Urinary Tract Infections (UTIs)
  • Others

By End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers & Academic Institutes
  • Long-term Care Facilities

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players 

  • Alpha Source Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • BioVigil
  • Gojo Industries Inc.
  • International Business Machines Corporation
  • Premier Inc.
  • RLDatix
  • S. C. Johnson & Son, Inc.
  • Wolters Kluwer
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in prevalence of healthcare associated infection
3.5.1.2.Technological advancement in healthcare sector
3.5.1.3.Initiative taken by government for prevention of healthcare associated infection

3.5.2.Restraint

3.5.2.1.High cost of software associated with infection surveillance solution

3.5.3.Opportunity

3.5.3.1.Growing opportunities in emerging market and development in healthcare industry

3.5.4.Impact analysis

3.6.Impact analysis of COVID-19 on the infection surveillance services market

CHAPTER 4:INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING

4.1.Overview

4.1.1.Market size and forecast

4.2.Software

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Software, by Type

4.2.2.1.Market size and forecast
4.2.2.2.On-premise

4.2.2.2.1.Market size and forecast

4.2.2.3.Web-based

4.2.2.3.1.Market size and forecast

4.2.3.Market size and forecast, by region
4.2.4.Market analysis, by country

4.3.Services

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Services, by type

4.3.2.1.Market size and forecast
4.3.2.2.Product Support & Maintenance Services

4.3.2.2.1.Market size and forecast

4.3.2.3.Training & Consulting Services

4.3.2.3.1.Market size and forecast

4.3.2.4.Implementation Services

4.3.2.4.1.Market size and forecast

4.3.3.Market size and forecast, by region
4.3.4.Market analysis, by country

CHAPTER 5:INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE

5.1.Overview

5.1.1.Market size and forecast

5.2.Hospital-acquired pneumonia

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country

5.3.Bloodstream infections

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country

5.4.Surgical site infections

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country

5.5.Gastrointestinal infections

5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by region
5.5.3.Market analysis, by country

5.6.Urinary Tract Infections (UTI)

5.6.1.Key market trends, growth factors, and opportunities
5.6.2.Market size and forecast, by region
5.6.3.Market analysis, by country

5.7.Others

5.7.1.Key market trends, growth factors, and opportunities
5.7.2.Market size and forecast, by region
5.7.3.Market analysis, by country

CHAPTER 6:INFECTION SURVEILLANCE SERVICES MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Hospitals & Clinics

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country

6.3.Ambulatory Surgical Centers & Academic Institutes

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country

6.4.Long term Care facilities

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market analysis, by country

CHAPTER 7:INFECTION SURVEILLANCE SERVICES  MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America  infection surveillance services  market, by offering
7.2.3.North America  infection surveillance services  market, by infection type
7.2.4.North America  infection surveillance services  market, by end user
7.2.5.Market size and forecast, by country

7.2.5.1.U.S.

7.2.5.1.1.U.S. infection surveillance services  market, by offering
7.2.5.1.2.U.S. infection surveillance services market, by infection type
7.2.5.1.3.U.S. infection surveillance services market, by end user

7.2.5.2.Canada

7.2.5.2.1.Canada infection surveillance services  market, by offering
7.2.5.2.2.Canada infection surveillance services market, by infection type
7.2.5.2.3.Canada infection surveillance services market, by end user

7.2.5.3.Mexico

7.2.5.3.1.Mexico infection surveillance services  market, by offering
7.2.5.3.2.Mexico infection surveillance services market, by infection type
7.2.5.3.3.Mexico infection surveillance services market, by end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe infection surveillance services  market, by offering
7.3.3.Europe infection surveillance services  market, by infection type
7.3.4.Europe infection surveillance services  market, by end user
7.3.5.Market size and forecast, by country

7.3.5.1.Germany

7.3.5.1.1.Germany infection surveillance services  market, by offering
7.3.5.1.2.Germany infection surveillance services market, by infection type
7.3.5.1.3.Germany infection surveillance services market, by end user

7.3.5.2.France

7.3.5.2.1.France infection surveillance services  market, by offering
7.3.5.2.2.France infection surveillance services market, by infection type
7.3.5.2.3.France infection surveillance services market, by end user

7.3.5.3.UK

7.3.5.3.1.UK infection surveillance services  market, by offering
7.3.5.3.2.UK infection surveillance services market, by infection type
7.3.5.3.3.UK infection surveillance services market, by end user

7.3.5.4.Italy

7.3.5.4.1.Italy infection surveillance services  market, by offering
7.3.5.4.2.Italy infection surveillance services market, by infection type
7.3.5.4.3.Italy infection surveillance services market, by end user

7.3.5.5.Spain

7.3.5.5.1.Spain infection surveillance services  market, by offering
7.3.5.5.2.Spain infection surveillance services market, by infection type
7.3.5.5.3.Spain infection surveillance services market, by end user

7.3.5.6.Rest of Europe

7.3.5.6.1.Rest of Europe infection surveillance services  market, by offering
7.3.5.6.2.Rest of Europe infection surveillance services market, by infection type
7.3.5.6.3.Rest of Europe infection surveillance services market, by end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific infection surveillance services  market, by offering
7.4.3.Asia-Pacific infection surveillance services  market, by infection type
7.4.4.Asia-Pacific infection surveillance services  market, by end user
7.4.5.Market size and forecast, by country

7.4.5.1.Japan

7.4.5.1.1.Japan infection surveillance services  market, by offering
7.4.5.1.2.Japan infection surveillance services market, by infection type
7.4.5.1.3.Japan infection surveillance services market, by end user

7.4.5.2.China

7.4.5.2.1.China infection surveillance services  market, by offering
7.4.5.2.2.China infection surveillance services market, by infection type
7.4.5.2.3.China infection surveillance services market, by end user

7.4.5.3.Australia

7.4.5.3.1.Australia infection surveillance services  market, by offering
7.4.5.3.2.Australia infection surveillance services market, by infection type
7.4.5.3.3.Australia infection surveillance services market, by end user

7.4.5.4.India

7.4.5.4.1.India infection surveillance services  market, by offering
7.4.5.4.2.India infection surveillance services market, by infection type
7.4.5.4.3.India infection surveillance services market, by end user

7.4.5.5.Rest of Asia-Pacific

7.4.5.5.1.Rest of Asia-Pacific infection surveillance services  market, by offering
7.4.5.5.2.Rest of Asia-Pacific infection surveillance services market, by infection type
7.4.5.5.3.Rest of Asia-Pacific infection surveillance services market, by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA  infection surveillance services  market, by offering
7.5.3.LAMEA infection surveillance services  market, by infection type
7.5.4.LAMEA infection surveillance services  market, by end user
7.5.5.Market size and forecast, by country

7.5.5.1.Brazil

7.5.5.1.1.Brazil infection surveillance services  market, by offering
7.5.5.1.2.Brazil infection surveillance services market, by infection type
7.5.5.1.3.Brazil infection surveillance services market, by end user

7.5.5.2.Saudi Arabia

7.5.5.2.1.Saudi Arabia infection surveillance services  market, by offering
7.5.5.2.2.Saudi Arabia infection surveillance services market, by infection type
7.5.5.2.3.Saudi Arabia infection surveillance services market, by end user

7.5.5.3.South Africa

7.5.5.3.1.South Africa infection surveillance services  market, by offering
7.5.5.3.2.South Africa infection surveillance services market, by infection type
7.5.5.3.3.South Africa infection surveillance services market, by end user

7.5.5.4.Rest of LAMEA

7.5.5.4.1.Rest of LAMEA infection surveillance services  market, by offering
7.5.5.4.2.Rest of LAMEA infection surveillance services market, by infection type
7.5.5.4.3.Rest of LAMEA infection surveillance services market, by end user

CHAPTER 8:COMPANY PROFILES

8.1.ALPHA SOURCE INC.

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio

8.2.BAXTER INTERNATIONAL INC

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments

8.3.BECTON, DICKINSON, AND COMPANY

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance

8.4.BIOVIGIL

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Key strategic moves and developments

8.5.GOJO INDUSTRIES INC.

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio

8.6.INTERNATIONAL BUSINESS MACHINES CORPORATION

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance

8.7.PREMIER INC.

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments

8.8.RL DATIX

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Key strategic moves and developments

8.9.S. C. JOHNSON & SON, INC.

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Key strategic moves and developments

8.10.WOLTERS KLUWER

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments

LIST OF TABLES

TABLE 01.GLOBAL INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 02.SOFTWARE MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 03.INFECTION SURVEILLANCE SERVICES MARKET FOR SOFTWARE, BY REGION, 2020-2030 ($MILLION)
TABLE 04.SERVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 05.INFECTION SURVEILLANCE SERVICES MARKET FOR SERVICES, BY REGION, 2020-2030 ($MILLION)
TABLE 06.GLOBAL INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 07.INFECTION SURVEILLANCE SERVICES MARKET FOR HOSPITAL-ACQUIRED PNEUMONIA, BY REGION, 2020-2030 ($MILLION)
TABLE 08.INFECTION SURVEILLANCE SERVICES MARKET FOR BLOODSTREAM INFECTION, BY REGION, 2020-2030 ($MILLION)
TABLE 09.INFECTION SURVEILLANCE SERVICES MARKET FOR SURGICAL SITE INFECTION, BY REGION, 2020-2030 ($MILLION)
TABLE 10.INFECTION SURVEILLANCE SERVICES MARKET FOR GASTROINTESTINAL INFECTIONS, BY REGION, 2020-2030 ($MILLION)
TABLE 11.INFECTION SURVEILLANCE SERVICES MARKET FOR URINARY TRACT INFECTIONS (UTI), BY REGION, 2020-2030 ($MILLION)
TABLE 12.INFECTION SURVEILLANCE SERVICES MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 13.GLOBAL INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 14.INFECTION SURVEILLANCE SERVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020-2030 ($MILLION)
TABLE 15.INFECTION SURVEILLANCE SERVICES MARKET FOR AMBULATORY SURGICAL CENTERS & ACADEMIC INSTITUTES, BY REGION, 2020-2030 ($MILLION)
TABLE 16.INFECTION SURVEILLANCE SERVICES MARKET FOR LONG TERM CARE FACILITIES, BY REGION, 2020-2030 ($MILLION)
TABLE 17.INFECTION SURVEILLANCE SERVICES  MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 18.NORTH AMERICA  INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 19.NORTH AMERICA  INFECTION SURVEILLANCE SERVICES  MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 20.NORTH AMERICA  INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 21.NORTH AMERICA  INFECTION SURVEILLANCE SERVICES  MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 22.U.S. INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 23.U.S. INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 24.U.S. INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 25.CANADA INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 26.CANADA INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 27.CANADA INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 28.MEXICO INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 29.MEXICO INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 30.MEXICO INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 31.EUROPE INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 32.EUROPE INFECTION SURVEILLANCE SERVICES  MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 33.EUROPE INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 34.EUROPE  INFECTION SURVEILLANCE SERVICES  MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 35.GERMANY INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 36.GERMANY INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 37.GERMANY INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 38.FRANCE INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 39.FRANCE INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 40.FRANCE INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 41.UK INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 42.UK INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 43.UK INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 44.ITALY INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 45.ITALY INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 46.ITALY INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 47.SPAIN INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 48.SPAIN INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 49.SPAIN INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 50.REST OF EUROPE INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 51.REST OF EUROPE INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 52.REST OF EUROPE INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 53.ASIA-PACIFIC INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 54.ASIA-PACIFIC INFECTION SURVEILLANCE SERVICES  MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 55.ASIA-PACIFIC INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 56.ASIA-PACIFIC  INFECTION SURVEILLANCE SERVICES  MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 57.JAPAN INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 58.JAPAN INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 59.JAPAN INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 60.CHINA INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 61.CHINA INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 62.CHINA INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 63.AUSTRALIA INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 64.AUSTRALIA INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 65.AUSTRALIA INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 66.INDIA INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 67.INDIA INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 68.INDIA INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 69.REST OF ASIA-PACIFIC INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 70.REST OF ASIA-PACIFIC INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 71.REST OF ASIA-PACIFIC INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 72.LAMEA INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 73.LAMEA INFECTION SURVEILLANCE SERVICES  MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 74.LAMEA INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 75.LAMEA  INFECTION SURVEILLANCE SERVICES  MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 76.BRAZIL INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 77.BRAZIL INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 78.BRAZIL INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 79.SAUDI ARABIA INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 80.SAUDI ARABIA INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 81.SAUDI ARABIA INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 82.SOUTH AFRICA INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 83.SOUTH AFRICA INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 84.SOUTH AFRICA INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 85.REST OF LAMEA INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 86.REST OF LAMEA INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 87.REST OF LAMEA INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 88.ALPHA: COMPANY SNAPSHOT
TABLE 89.ALPHA: OPERATING SEGMENTS
TABLE 90.ALPHA: PRODUCT PORTFOLIO
TABLE 91.BAXTER: COMPANY SNAPSHOT
TABLE 92.BAXTER: OPERATING SEGMENTS
TABLE 93.BAXTER: PRODUCT PORTFOLIO
TABLE 94.BAXTER: KEY DEVELOPMENTS
TABLE 95.BD: COMPANY SNAPSHOT
TABLE 96.BD: OPERATING SEGMENTS
TABLE 97.BD: PRODUCT PORTFOLIO
TABLE 98.BIOVIGIL: COMPANY SNAPSHOT
TABLE 99.BIOVIGIL: PRODUCT SEGMENTS
TABLE 100.BIOVIGIL: PRODUCT PORTFOLIO
TABLE 101.BIOVIGIL: KEY DEVELOPMENTS
TABLE 102.GOJO: COMPANY SNAPSHOT
TABLE 103.GOJO: PRODUCT SEGMENTS
TABLE 104.GE: PRODUCT PORTFOLIO
TABLE 105.IBM: COMPANY SNAPSHOT
TABLE 106.IBM: PRODUCT SEGMENTS
TABLE 107.IBM: PRODUCT PORTFOLIO
TABLE 108.PREMIER: COMPANY SNAPSHOT
TABLE 109.PREMIER: OPERATING SEGMENTS
TABLE 110.PREMIER: PRODUCT PORTFOLIO
TABLE 111.PREMIER: KEY DEVELOPMENTS
TABLE 112.RL: COMPANY SNAPSHOT
TABLE 113.RL: OPERATING SEGMENTS
TABLE 114.RL: PRODUCT PORTFOLIO
TABLE 115.PREMIER: KEY DEVELOPMENTS
TABLE 116.JOHNSON: COMPANY SNAPSHOT
TABLE 117.JOHNSON: OPERATING BUSINESS SEGMENTS
TABLE 118.JOHNSON: PRODUCT PORTFOLIO
TABLE 119.JOHNSON: KEY DEVELOPMENTS
TABLE 120.WOLTERS: COMPANY SNAPSHOT
TABLE 121.WOLTERS: OPERATING BUSINESS SEGMENTS
TABLE 122.WOLTERS: PRODUCT PORTFOLIO
TABLE 123.WOLTERS: KEY DEVELOPMENTS

LIST OF FIGURES

FIGURE 01.INFECTION SURVEILLANCE SERVICES MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2020
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2020
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2020
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF INFECTION SURVEILLANCE SERVICES MARKET FOR SOFTWARE, BY COUNTRY, 2020-2030 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF INFECTION SURVEILLANCE SERVICES MARKET FOR SERVICES, BY COUNTRY, 2020-2030 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF INFECTION SURVEILLANCE SERVICES MARKET FOR HOSPITAL-ACQUIRED PNEUMONIA, BY COUNTRY, 2020-2030 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF INFECTION SURVEILLANCE SERVICES MARKET FOR BLOODSTREAM INFECTION, BY COUNTRY, 2020-2030 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF INFECTION SURVEILLANCE SERVICES MARKET FOR SURGICAL SITE INFECTION, BY COUNTRY, 2020-2030 (%)
FIGURE 18.COMPARATIVE ANALYSIS OF INFECTION SURVEILLANCE SERVICES MARKET FOR GASTROINTESTINAL INFECTIONS, BY COUNTRY, 2020-2030 (%)
FIGURE 19.COMPARATIVE ANALYSIS OF INFECTION SURVEILLANCE SERVICES MARKET FOR URINARY TRACT INFECTIONS (UTI), BY COUNTRY, 2020-2030 (%)
FIGURE 20.COMPARATIVE ANALYSIS OF INFECTION SURVEILLANCE SERVICES MARKET FOR OTHERS, BY COUNTRY, 2020-2030 (%)
FIGURE 21.COMPARATIVE ANALYSIS OF INFECTION SURVEILLANCE SERVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020-2030 (%)
FIGURE 22.COMPARATIVE ANALYSIS OF INFECTION SURVEILLANCE SERVICES MARKET FOR AMBULATORY SURGICAL CENTERS & ACADEMIC INSTITUTES, BY COUNTRY, 2020-2030 (%)
FIGURE 23.COMPARATIVE ANALYSIS OF INFECTION SURVEILLANCE SERVICES MARKET FOR LONG TERM CARE FACILITIES, BY COUNTRY, 2020-2030 (%)
FIGURE 24.BAXTER: NET SALES, 2018–2020 ($MILLION)
FIGURE 25.BAXTER: REVENUE SHARE BY REGION, 2020(%)
FIGURE 26.BD: NET SALES, 2018–2020 ($MILLION)
FIGURE 27.BD: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 28.BD: REVENUE SHARE BY REGION, 2020(%)
FIGURE 29.IBM: NET SALES, 2018–2020 ($MILLION)
FIGURE 30.IBM: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 31.IBM: REVENUE SHARE BY REGION, 2020(%)
FIGURE 32.PREMIER: NET SALES, 2018–2021 ($MILLION)
FIGURE 33.PREMIER: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 34.WOLTERS: NET SALES, 2018–2020 ($MILLION)
FIGURE 35.WOLTERS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 36.WOLTERS: REVENUE SHARE BY REGION, 2020 (%)

 
 

Growth of the infection surveillance services market is attributed to factors such as technological advancements in the healthcare sector; rise in prevalence of healthcare-associated infection such as surgical site infection, pneumonia, and urinary tract infection; increase in funds from private and government organizations for various infection prevention and control projects; and surge in the number of surgeries. The infection surveillance services market gains interest of healthcare information technology companies, owing to surge in demand for electronic medical record and fully automated healthcare-associated infection and specialized data mining software. This leads to increase in adoption of infection surveillance system in hospital for effective data collection of patients. Moreover, increase in antibiotic resistance of bacteria, lack of sanitization, improvement in healthcare infrastructure, and initiatives taken by governments for development of technology in the healthcare sector and preventive measures for healthcare-associated infection propel the growth of the market.

North America is expected to witness highest growth, in terms of revenue, owing to rise in prevalence of healthcare-associated infection, presence of key players, and advancements in healthcare information technology.

Asia-Pacific was the second largest contributor to the market in 2020, and is expected to register the fastest CAGR during the forecast period, owing to increase in prevalence of healthcare-associated infection, rise in the number of surgical procedures, and rise in adoption of infection surveillance software among healthcare workers.

However, high cost of software associated with infection surveillance software is anticipated to restrain the market growth during the forecast period.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of infection surveillance services Market is $407.06 million in 2020.

A. The forecast period in the report is from 2021 to 2030

A. The market value of infection surveillance services Market in 2021 was $508.38 million

A. The base year for the report is 2020.

A. Yes, infection surveillance services companies are profiled in the report

A. The top companies that hold the market share in human identification market are Alpha Source Inc., Baxter International Inc., Becton, Dickinson and Company, BioVigil, Gojo Industries Inc., International Business Machines Corporation, Premier Inc., RLDatix, S. C. Johnson & Son, Inc., and Wolters Kluwer

A. No, there is no value chain analysis provided in the human identification Market report

A. The key trends in the infection surveillance servicesmarket are increase in the prevalence of healthcare associated infection, such as urinary tract infection, pneumonia, and surgical site infection, rise in government initiative for prevention and control of HAI, surge in number of surgical procedures, advancement in the technology of healthcare, and rise in resistance of microbes and bacteria towards antibiotics

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Infection Surveillance Services Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers